These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6772589)

  • 1. The use of immunopotentiators in malaria.
    Strickland GT; Hunter KW
    Int J Nucl Med Biol; 1980; 7(2):133-40. PubMed ID: 6772589
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
    Theilen GH; Hills D
    J Am Vet Med Assoc; 1982 Nov; 181(10):1134-41. PubMed ID: 6757216
    [No Abstract]   [Full Text] [Related]  

  • 3. Nor-MDP, saponin, corynebacteria, and pertussis organisms as immunological adjuvants in experimental malaria vaccination of macaques.
    Mitchell GH; Richards WH; Voller A; Dietrich FM; Dukor P
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):189-97. PubMed ID: 232428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against malaria: evaluation of a plasmodial vaccine fraction and a preliminary study of some immunologic adjuvants in a primate model system: a brief report.
    D'Antonio LE
    J Am Osteopath Assoc; 1974 Apr; 73(8):649-52. PubMed ID: 4207618
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmodium berghei: immunologic enhancement of antigen by adjuvant addition.
    Desowitz RS
    Exp Parasitol; 1975 Aug; 38(1):6-13. PubMed ID: 1097263
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse.
    McColm AA; Bomford R; Dalton L
    Parasite Immunol; 1982 Sep; 4(5):337-47. PubMed ID: 7145465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunity adjuvants and antihistaminic activity].
    Lallouette P; Richou R; Legger H; Schwartz A
    C R Acad Hebd Seances Acad Sci D; 1969 Jan; 268(2):465-7. PubMed ID: 4388265
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Malaria vaccines.
    Silverman PH
    Br Med J; 1975 May; 2(5966):335-6. PubMed ID: 805622
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of action by immunologic adjuvants.
    Osebold JW
    J Am Vet Med Assoc; 1982 Nov; 181(10):983-7. PubMed ID: 6294032
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant protection against bacterial infection in granulocytopenic mice.
    Buhles WC; Shifrine M
    J Infect Dis; 1977 Jul; 136(1):90-5. PubMed ID: 328788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of metozoite vaccination against Plasmodium knowlesi malaria.
    Mitchell GH
    Trans R Soc Trop Med Hyg; 1977; 71(4):281-2. PubMed ID: 413214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the efficacy of different adjuvants in live stock specific bacterial vaccines for turkeys against Bordetella infection and onset of antibody titers in respect to the age of the turkey poults.
    Glünder G; van der Ven H; Foulman A
    Pol J Vet Sci; 2004; 7(2):77-81. PubMed ID: 15230536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
    El Kappany H; Chopra C; Nigam VN; Brailovsky CA; Elhilali M
    Br J Cancer; 1980 Nov; 42(5):703-11. PubMed ID: 7459208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
    Moroson H; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation.
    Rahimian S; Fransen MF; Kleinovink JW; Christensen JR; Amidi M; Hennink WE; Ossendorp F
    J Control Release; 2015 Apr; 203():16-22. PubMed ID: 25660830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of Rhesus monkeys (Macaca mulatta) against Plasmodium knowlesi by the use of nonviable antigen.
    Schenkel RH; Simpson GL; Silverman PH
    Bull World Health Organ; 1973 May; 48(5):597-604. PubMed ID: 4204492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy of lung cancer].
    Jassem J; Jassem E
    Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
    [No Abstract]   [Full Text] [Related]  

  • 18. [The stimulating effect of linol on the formation of group-specific complement-fixing antibodies with respect to adenoviruses].
    Kvitash VI; Kiris ND
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Sep; 45(9):101-4. PubMed ID: 4305816
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection against Plasmodium chabaudi malaria. I.--Vaccination of mice with merozoites and Freund's adjuvants.
    Hommel M; David PH; Guillotte M; Pereira da Silva L
    Ann Immunol (Paris); 1982; 133C(1):57-67. PubMed ID: 7092175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvants in specific desensitizing therapy].
    Dal Bo S
    Folia Allergol (Roma); 1969; 16(4):424-5. PubMed ID: 5400583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.